Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sanofi-Aventis S.A. ADR
(NQ:
SNY
)
49.28
+0.59 (+1.21%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi-Aventis S.A. ADR
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
May 15, 2021
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back...
Via
Talk Markets
Exposures
Product Safety
The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off
May 15, 2021
Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the...
Via
Benzinga
Exposures
Product Safety
15 European Dividend Aristocrats To Diversify Your Portfolio
May 12, 2021
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that...
Via
Benzinga
Daily Stock Analysis: Sanofi (SNY)
April 28, 2021
Sanofi's price per share closed at $51.50 yesterday. One year ago its price was $49.87.
Via
Talk Markets
Novavax Reports Positive Data From Animal Trial of Its COVID-19/Flu Combo Shot
May 12, 2021
Human trials of the combination vaccine are expected to start later this year.
Via
The Motley Fool
Exposures
COVID-19
Is Sanofi a Good Buy in 2021?
May 12, 2021
You might want to add this international blue-chip stock to your portfolio.
Via
The Motley Fool
FDA Outlines Plan For Restarting Facility Inspections Halted Due To Pandemic
May 10, 2021
The FDA has published a roadmap for working through the backlog of facility inspections built up during the pandemic when it postponed all routine inspections in March...
Via
Benzinga
Exposures
Product Safety
5 Value Stocks In The Healthcare Sector
May 10, 2021
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples...
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Could AstraZeneca and Sanofi Win Big in RSV?
May 08, 2021
The companies have a promising RSV candidate.
Via
The Motley Fool
Regeneron Reports Mixed Bag On Q1 Earnings; Eylea Franchise Boosts Revenue
May 06, 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned $9.89 per share for the first quarter, beating the $9.03 estimate. Revenue of $2.53 billion narrowly missed...
Via
Benzinga
Avrobio Plans Registration Trial With Kidney Biopsy Endpoint To Support Potential Full Approval Of Fabry Disease Gene Therapy
May 03, 2021
Avrobio Inc (NASDAQ: AVRO) has provided an update on its regulatory plans for AVR-RD-01, its lentiviral gene therapy for Fabry disease, currently in FAB-GT Phase 2...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 03, 2021
Gainers BioVie (NASDAQ:BIVI) shares increased by 12.96% to $19.78 during Monday's pre-market session. The company's market cap stands at $275.2 million. Ocugen (...
Via
Benzinga
22 Stocks Moving in Monday's Pre-Market Session
May 03, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) rose 58.3% to $78.90 in pre-market trading. Nicholas Jason Singer disclosed a 9.13% passive stake in Brooklyn...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
Product Safety
70 Firms Going Ex-Dividend Next Week, Including Walmart, BP And Pfizer
May 01, 2021
There are several well known large cap stocks going ex-dividend next week. Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to...
Via
Talk Markets
Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
May 01, 2021
Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...
Via
Benzinga
Moderna Tries To Boost COVID-19 Vaccine Supply Chain To Produce 3B Doses Annually
April 29, 2021
Moderna Inc (NASDAQ: MRNA) plans to produce up to 3 billion doses in 2022, doubling capacity at contract sites in Switzerland and Spain run by Lonza Group...
Via
Benzinga
Exposures
COVID-19
Moderna Stock Near Breakout As Company Boosts Its Covid Vaccines Outlook
April 29, 2021
Moderna boosted its forecast for Covid vaccine doses in 2021 and 2022, in a move early Thursday that could send Moderna stock into a breakout.
Via
Investor's Business Daily
Exposures
COVID-19
Sanofi SA (SNY) Q1 2021 Earnings Call Transcript
April 28, 2021
SNY earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Sanofi Shares Rise On Q1 Sales Boosted By Dupixent Franchise; Plans To Restart Haemophilia Study With Fitusiran
April 28, 2021
Sanofi SA (NASDAQ: SNY) stock climbed after its Q1 earnings beat earnings expectations and stuck to its full-year guidance, as well as reported progress on its...
Via
Benzinga
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Exposures
Product Safety
Big Earnings Week Ahead To Close April In Style
April 26, 2021
Last week, the Dow Jones Industrial Average, S&P 500 and Nasdaq broke multiweek winning streaks with modest losses despite Friday's rally. This week's earnings will...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine
April 26, 2021
As the demand for mRNA-based COVID-19 vaccines persists, Sanofi SA (NASDAQ: SNY) has entered an agreement with Moderna Inc (NASDAQ: MRNA)...
Via
Benzinga
Exposures
COVID-19
Sanofi-AstraZeneca's Nirsevimab Hits Primary Endpoint Goal In Late-Stage RSV Disease In Infants
April 26, 2021
Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc’s (NASDAQ: AZN) monoclonal antibody (mAb) nirsevimab has reached its primary endpoint in a...
Via
Benzinga
BioNTech CFO Sees Scope For Additional Production Sites To Meet Demand For COVID-19 Shots: Reuters
April 21, 2021
Pfizer Inc's (NYSE: PFE) COVID-19 vaccine partner BioNTech SE (NASDAQ: BNTX) is not ruling out further capacity expansion and new production...
Via
Benzinga
Exposures
COVID-19
Here’s What $1,000 Invested In Vaccine Stocks Would Be Worth Now
April 19, 2021
It’s often said that with every crisis comes great opportunity. While such catastrophes do create upheaval and uncertainty in financial markets, they can also lead to new opportunities for investors,...
Via
Talk Markets
5 Value Stocks To Watch In The Healthcare Sector
April 12, 2021
What Defines a Value Stock? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
< Previous
1
2
...
20
21
22
23
24
25
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.